BIOS Capital Management as of Sept. 30, 2025
Portfolio Holdings for BIOS Capital Management
BIOS Capital Management holds 6 positions in its portfolio as reported in the September 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Actuate Therapeutics (ACTU) | 75.6 | $67M | 10M | 6.69 | |
| Cognition Therapeutics (CGTX) | 9.1 | $8.1M | 6.0M | 1.35 | |
| Ocuphire Pharma (IRD) | 7.4 | $6.6M | 3.7M | 1.79 | |
| Lantern Pharma (LTRN) | 5.0 | $4.4M | 1.0M | 4.35 | |
| Rein Therapeutics Com New (RNTX) | 2.2 | $1.9M | 1.7M | 1.15 | |
| In8bio | 0.7 | $622k | 287k | 2.17 |
